PositionBrief article

The Committee on Industry (ITRE) of the European Parliament adopted with a large majority, on 23 January, the Innovative Medicines Initiative 2 (IMI2) joint undertaking. IMI2 is a public-private partnership between the European Commission and the bio-pharmaceutical industry, whose goal is to improve the process of developing medicines and new treatments, and support cooperation on research and development. "The first IMI initiative, between 2007 and 2013, allowed for the funding of 40 projects and the development new therapies for...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT